Paolo Mascagni

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

Flavio Leoni, Andrea Zaliani, Giorgio Bertolini et al. · Proceedings of the National Academy of Sciences · 2002 · 509 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo

Flavio Leoni, Gianluca Fossati, Eli C. Lewis et al. · Molecular Medicine · 2005 · 333 citations · Full text

Medicine, Immunology, Pharmacology +17

Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice

Rainer Glauben, Arvind Batra, I Fedke et al. · The Journal of Immunology · 2006 · 293 citations · Full text

Medicine, Oncology, Pharmacology +16

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

Pavan Reddy, Yaping Sun, Tomomi Toubai et al. · Journal of Clinical Investigation · 2008 · 267 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Pharmacological Inhibition of Histone Deacetylases by Suberoylanilide Hydroxamic Acid Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse Brain

Giuseppe Faraco, Tristano Pancani, Laura Formentini et al. · Molecular Pharmacology · 2006 · 256 citations

Medicine, Neuroscience, Pharmacology +16